Sunil Bodapati

Sunil Bodapati is the CEO of Enable Medicine, a position they have held since June 2018. Prior to joining Enable Medicine, they were a product manager at Color Genomics, where they were responsible for product efforts across enterprise and research channels. Sunil left Color to start a PhD at Stanford.

Bodapati has also worked as a forward deployed engineer and business development manager at Palantir Technologies, and as a summer analyst at Artiman Ventures. Sunil has also served as head of product at Aurora Technologies and as a student researcher at Cambridge University.

Bodapati's research experience includes work on infectious disease detection with the Gambhir Lab at Stanford University. Sunil has also conducted market research in technologies pertaining to infectious disease detection, sat in pitch meetings and helped in due diligence, and validated technological competitive edge for prospective portfolio companies.

Sunil Bodapati has a Ph.D. in Bioengineering from Stanford University and a BS in Bioengineering from Stanford University. Sunil also attended Bellarmine College Preparatory.

Some direct reports include Aaron Mayer - CSO, George Finnerty - Business Operations, and Brittany Goulart - Operations Lead; Executive Assistant to the CSO and CEO.